STOCK TITAN
  1. Home
  2. Sec-filings
  3. LUCD
  4. [EFFECT] Lucid Diagnostics Inc. SEC Filing

[EFFECT] Lucid Diagnostics Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 26, 2026 4:30 P.M.
Form: S-3
CIK: 0001799011
Company Name: Lucid Diagnostics Inc.
File Number: 333-291981

Source: View Original Filing on SEC EDGAR

Lucid Diagnostics Inc.

NASDAQ:LUCD

View LUCD Stock Overview →

LUCD Rankings

#4502 Ranked by Market Cap
N/A Ranked by Dividends

LUCD Latest News

Apr 2, 2026
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
Mar 30, 2026
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 26, 2026
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 16, 2026
PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026
Mar 12, 2026
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026

LUCD Latest SEC Filings

Mar 26, 2026
[424B5] Lucid Diagnostics Inc. Prospectus Supplement (Debt Securities)
Mar 26, 2026
[8-K] Lucid Diagnostics Inc. Reports Material Event
Mar 25, 2026
[S-3/A] Lucid Diagnostics Inc. Amended Shelf Registration Statement
Mar 25, 2026
[10-K] Lucid Diagnostics Inc. Files Annual Report
Feb 24, 2026
[Form 4] Lucid Diagnostics Inc. Insider Trading Activity

LUCD Stock Data

195.92M
126.24M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NEW YORK